Cargando…
Predicting response to immunotherapy in non-small cell lung cancer- from bench to bedside
BACKGROUND: Immune checkpoint inhibitor (ICI) therapy is first-line treatment for many advanced non-small cell lung cancer (aNSCLC) patients. Predicting response could help guide selection of intensified or alternative anti-cancer regimens. We hypothesized that radiomics and laboratory variables pre...
Autores principales: | Montoya, Chris, Spieler, Benjamin, Welford, Scott M., Kwon, Deukwoo, Pra, Alan Dal, Lopes, Gilberto, Mihaylov, Ivaylo B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10686412/ https://www.ncbi.nlm.nih.gov/pubmed/38033493 http://dx.doi.org/10.3389/fonc.2023.1225720 |
Ejemplares similares
-
Lung Inflammation Predictors in Combined Immune Checkpoint-Inhibitor and Radiation Therapy—Proof-of-Concept Animal Study
por: Spieler, Benjamin, et al.
Publicado: (2022) -
Abscopal effect observed in visceral and osseous metastases after liver SBRT in combination with nivolumab and relatlimab for sinonasal mucosal melanoma—a case report
por: Cerbon, Danielle, et al.
Publicado: (2023) -
Erring Characteristics of Deformable Image Registration-Based Auto-Propagation for Internal Target Volume in Radiotherapy of Locally Advanced Non-Small Cell Lung Cancer
por: Rich, Benjamin J., et al.
Publicado: (2022) -
Targeting Macrophages in Cancer: From Bench to Bedside
por: Poh, Ashleigh R., et al.
Publicado: (2018) -
Toward prediction of abscopal effect in radioimmunotherapy: Pre-clinical investigation
por: Mihaylov, Ivaylo B., et al.
Publicado: (2021)